Shopping cart

Subtotal $0.00

View cartCheckout

Subscribe to our newsletter today and receive more information on health, wellness and the latest medical treatments.

20 N Front St Bally, PA 19503

contact@elxrt.com

+1 (866) 218-5543

Let’s Stay In Touch

Contact Us

+1 (866) 218 5543

Monday - Fri

9 AM to 5 PM

MAT & Suboxone FAQs

  • Home
  • MAT & Suboxone FAQs
Untitled 1 1You Have Questions?

Here are the answers

Medication-Assisted Treatment (MAT) is used to treat substance use disorders and support recovery by combining medication with counseling and behavioral therapies. Candidates for MAT include individuals:

  • With a diagnosis of opioid use disorder (OUD), including those addicted to heroin and prescription pain relievers containing opiates.
  • Who have a diagnosis of alcohol use disorder.
  • Who are motivated to treat their substance use disorder and are willing to follow a comprehensive treatment plan that includes behavioral therapy and medication.
  • Who have been assessed by a healthcare professional as meeting criteria for substance use disorder treatment.
  • Who understand the importance of medication compliance as part of their overall treatment plan.
  • Pregnant women with opioid use disorders, to improve neonatal outcomes and support the health of the mother.
  • Individuals unable to achieve or sustain recovery with non-pharmacological interventions alone.
  • Those for whom the benefits of MAT outweigh the potential risks, including individuals with co-occurring mental health disorders.
  • People who have experienced a recent overdose or have a high risk of opioid overdose.
  • Patients in settings where MAT can be effectively monitored and supported, such as inpatient treatment facilities, outpatient treatment programs, or primary care settings integrated with addiction care.

It's important for individuals to undergo a thorough evaluation by healthcare professionals specializing in addiction treatment to determine the most appropriate treatment approach, including the suitability for MAT.

  • Adults 18+ with an opioid or other addiction who are seeking recovery and remission.
  • Post-detox patients requiring medication-assisted maintenance.
  • Those assessed as benefiting from Suboxone or MAT without managed misuse risks.
  • People committed to comprehensive recovery plans, including therapy.
  • Those who have no contraindications for safe Suboxone use and have provided informed consent after understanding the effects and risks.
  • Some pregnant women may be considered when under strict medical oversight.
  • Regularly using opioids or alcohol and want to halt their use.
  • Individuals who don't require a higher level of care for acute medical or psychiatric issues.

MAT Prescription meds:

  • Suboxone 
  • Generic Buprenorphine + Naloxone

Revia is an FDA-approved medication known as an opiate antagonist that is prescribed to combat alcohol use disorder (AUD) and opioid use disorder (OUD) comes in daily pills. It may be prescribed by licensed practitioners to adults 18+ as part of a broader treatment plan.

Vivitrol, also known by its generic name Naltrexone, is a prescription medication used in the treatment of alcohol dependence and opioid dependence. Administered as a once-monthly injection by a healthcare provider, Vivitrol is part of a comprehensive management plan that includes psychological support and lifestyle changes. It works by blocking the euphoric effects and feelings of intoxication, helping to prevent relapse in people who have already detoxified. Vivitrol acts on the brain's reward system to reduce the craving for alcohol or opioids, making it easier for patients to abstain from substance use. This medication is an integral component of a holistic approach to addiction recovery, emphasizing its role in supporting long-term sobriety and improving quality of life. Before starting Vivitrol, it's important for patients to discuss their medical history with their healthcare provider.  

Contraindications and safety information. 

  • Monthly Provider Visits
  • Medication management 
  • Ongoing support from the dedicated ELXR care team

Patients are required to get tested once a month after their initial visit to monitor progress. Successful treatment starts with "staying clean."

Our care coordinator will arrange that for you.

ELXR program uses a seamless HIPAA and HITECH-compliant telehealth video platform for consultations with your medical provider. You will receive instructions on how to use the system before your first visit. (its simple)

No. ELXR doesn't accept medical insurance and is considered a self-pay program. 

Yes, insurance covers your prescription.

Individuals using opioids who wish to reduce or stop their use and do not require acute medical or psychiatric care are eligible for our program.

Absolutely. We prioritize your privacy and confidentiality above all else. Your information is securely handled and will never be shared without your explicit consent.  We will never share your information with anyone without your permission. Read more about our Privacy Policy.

We are currently treating patients with opioid and other addictions in Pennsylvania but will be expanding to other states.

Some pharmacies deliver like Express Scripts but most of the time we will send your script to the patient’s local pharmacy.

ELXR’s providers primarily prescribe:

  • Suboxone 
  • Generic Buprenorphine + Naloxone

Have Any Other Questions?